Skip to main
CTSH
CTSH logo

CTSH Stock Forecast & Price Target

CTSH Analyst Ratings

Based on 38 analyst ratings
Hold
Strong Buy 16%
Buy 29%
Hold 47%
Sell 3%
Strong Sell 5%

Bulls say

Cognizant Tech Solutions demonstrated strong performance in its Health Sciences segment, achieving a year-over-year constant currency revenue growth of 10.4%, while the overall revenue increased by 6.7% in constant currency terms. Bookings for the quarter rose by 11% year-over-year, contributing to a trailing twelve-month (TTM) bookings total of $27.1 billion, reflecting a solid book-to-bill ratio of 1.4. Additionally, the company is poised for enhanced operating margin growth of 20 to 40 basis points, supported by advancements in AI and automation, reinforcing a positive outlook for the company’s financial trajectory.

Bears say

Cognizant Technology Solutions faces a negative outlook primarily due to a slight decrease in blended utilization amid the integration of its recent acquisition, Belcan, which has led to a turbulent demand environment for IT services. Revenue growth is projected to decelerate as global technology spending contracts due to macroeconomic challenges and a lack of traction in next-generation services. Furthermore, a 1% sequential decline in headcount reflects the company's need to right-size its workforce, pointing to subdued demand for discretionary IT services, which may hinder Cognizant’s ability to meet growth expectations in the near term.

CTSH has been analyzed by 38 analysts, with a consensus rating of Hold. 16% of analysts recommend a Strong Buy, 29% recommend Buy, 47% suggest Holding, 3% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cognizant Technology Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cognizant Technology Solutions (CTSH) Forecast

Analysts have given CTSH a Hold based on their latest research and market trends.

According to 38 analysts, CTSH has a Hold consensus rating as of Jul 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cognizant Technology Solutions (CTSH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.